Literature DB >> 22926011

Estrogen stimulates the proliferation of human endometrial cancer cells by stabilizing nucleophosmin/B23 (NPM/B23).

Angel Chao1, Chiao-Yun Lin, Chia-Lung Tsai, Swei Hsueh, Ying-Yu Lin, Cheng-Tao Lin, Hung-Hsueh Chou, Tzu-Hao Wang, Chyong-Huey Lai, Hsin-Shih Wang.   

Abstract

Unopposed estrogen exposure is an important factor in the tumorigenesis of endometrial cancer. Nucleophosmin/B23 (NPM/B23), a phosphoprotein that has pleiotropic functions in cells, plays an important role in various cancers. However, the regulatory role of NPM/B23 in estrogen signaling in endometrial cancer has not been explored. Here, we report that NPM/B23 was required for estrogen-induced endometrial proliferation, and the increase in NPM/B23 was estrogen receptor α-dependent. Furthermore, estrogen increased NPM/B23 protein levels by repressing its ubiquitination and subsequently stabilizing the protein. The overexpression of the alternate reading frame (ARF) suppressed the estrogen-induced increase in the NPM/B23 protein levels, indicating that ARF inhibited the observed estrogen-mediated NPM/B23 stabilization. Our results suggest that one of the effects of estrogen on endometrial proliferation is the suppression of the NPM/B23-ARF interaction and the subsequent increase in NPM/B23 protein levels. This novel characterization of NPM/B23 in estrogen-mediated cell proliferation may extend our understanding of the tumorigenesis of steroid hormone-related cancers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22926011     DOI: 10.1007/s00109-012-0950-8

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  33 in total

1.  Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation.

Authors:  Koji Itahana; Krishna P Bhat; Aiwen Jin; Yoko Itahana; David Hawke; Ryuji Kobayashi; Yanping Zhang
Journal:  Mol Cell       Date:  2003-11       Impact factor: 17.970

2.  Expression patterns among interferon regulatory factor-1, human X-box binding protein-1, nuclear factor kappa B, nucleophosmin, estrogen receptor-alpha and progesterone receptor proteins in breast cancer tissue microarrays.

Authors:  Yuelin Zhu; Baljit Singh; Stephen Hewitt; Aiyi Liu; Bianca Gomez; Antai Wang; Robert Clarke
Journal:  Int J Oncol       Date:  2006-01       Impact factor: 5.650

3.  Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.

Authors:  A Chao; C-Y Lin; Y-S Lee; C-L Tsai; P-C Wei; S Hsueh; T-I Wu; C-N Tsai; C-J Wang; A-S Chao; T-H Wang; C-H Lai
Journal:  Oncogene       Date:  2011-07-04       Impact factor: 9.867

4.  Nucleophosmin is required for DNA integrity and p19Arf protein stability.

Authors:  Emanuela Colombo; Paola Bonetti; Eros Lazzerini Denchi; Paola Martinelli; Raffaella Zamponi; Jean-Christophe Marine; Kristian Helin; Brunangelo Falini; Pier Giuseppe Pelicci
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

5.  Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4-216) recognizes nucleophosmin/B23.

Authors:  E N Subong; M J Shue; J I Epstein; J V Briggman; P K Chan; A W Partin
Journal:  Prostate       Date:  1999-06-01       Impact factor: 4.104

6.  Decreased expression of microRNA-199b increases protein levels of SET (protein phosphatase 2A inhibitor) in human choriocarcinoma.

Authors:  Angel Chao; Chia-Lung Tsai; Pei-Chi Wei; Swei Hsueh; An-Shine Chao; Chin-Jung Wang; Chi-Neu Tsai; Yun-Shien Lee; Tzu-Hao Wang; Chyong-Huey Lai
Journal:  Cancer Lett       Date:  2009-11-08       Impact factor: 8.679

7.  Hypoxia-induced nucleophosmin protects cell death through inhibition of p53.

Authors:  June Li; Xiaoling Zhang; Daniel P Sejas; Grover C Bagby; Qishen Pang
Journal:  J Biol Chem       Date:  2004-08-13       Impact factor: 5.157

8.  Sumoylation of nucleophosmin/B23 regulates its subcellular localization, mediating cell proliferation and survival.

Authors:  Xia Liu; Zhixue Liu; Sung-Wuk Jang; Zhiyong Ma; Kazuya Shinmura; Sumin Kang; Shaozhong Dong; Jing Chen; Kenji Fukasawa; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

Review 9.  The role of nucleophosmin in centrosome duplication.

Authors:  Masaru Okuda
Journal:  Oncogene       Date:  2002-09-09       Impact factor: 9.867

10.  Runt-related transcription factor RUNX3 is a target of MDM2-mediated ubiquitination.

Authors:  Xin-Zi Chi; Jiyeon Kim; Yong-Hee Lee; Jung-Won Lee; Kyeong-Sook Lee; Heejun Wee; Wun-Jae Kim; Woo-Yoon Park; Byung-Chul Oh; Gary S Stein; Yoshiaki Ito; Andre J van Wijnen; Suk-Chul Bae
Journal:  Cancer Res       Date:  2009-10-06       Impact factor: 12.701

View more
  8 in total

1.  Impact of NPM, TFF3 and TACC1 on the prognosis of patients with primary gastric cancer.

Authors:  Aiping Ding; Wenwen Zhao; Xiaoli Shi; Ruyong Yao; Fang Zhou; Lu Yue; Shihai Liu; Wensheng Qiu
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

2.  Estrogen mediated expression of nucleophosmin 1 in human endometrial carcinoma clinical stages through estrogen receptor-α signaling.

Authors:  Yunxiao Zhou; Jie Shen; Liqun Xia; Yanli Wang
Journal:  Cancer Cell Int       Date:  2014-12-20       Impact factor: 5.722

3.  Lysine-specific demethylase 1 (LSD1) destabilizes p62 and inhibits autophagy in gynecologic malignancies.

Authors:  Angel Chao; Chiao-Yun Lin; An-Ning Chao; Chia-Lung Tsai; Ming-Yu Chen; Li-Yu Lee; Ting-Chang Chang; Tzu-Hao Wang; Chyong-Huey Lai; Hsin-Shih Wang
Journal:  Oncotarget       Date:  2017-08-10

Review 4.  Implications of telomeres and telomerase in endometrial pathology.

Authors:  D K Hapangama; A Kamal; G Saretzki
Journal:  Hum Reprod Update       Date:  2017-03-01       Impact factor: 15.610

5.  Poor prognosis of nucleophosmin overexpression in solid tumors: a meta-analysis.

Authors:  Siying Chen; Hairong He; Yan Wang; Leichao Liu; Yang Liu; Haisheng You; Yalin Dong; Jun Lyu
Journal:  BMC Cancer       Date:  2018-08-20       Impact factor: 4.430

6.  Expression and functional studies on the noncoding RNA, PRINS.

Authors:  Krisztina Szegedi; Anikó Göblös; Sarolta Bacsa; Mária Antal; István Balázs Németh; Zsuzsanna Bata-Csörgő; Lajos Kemény; Attila Dobozy; Márta Széll
Journal:  Int J Mol Sci       Date:  2012-12-21       Impact factor: 5.923

7.  Comparing protective effect of grape seed extract versus atorvastatin on endometriosis in rat model: Evidence for immunohistochemical and biochemical alterations.

Authors:  Arash Kakaiy; Esmail Ayen; Rajabali Sadrkhanlou; Farshid Sarrafzadeh Rezaei
Journal:  Vet Res Forum       Date:  2015-06-15       Impact factor: 1.054

8.  Nucleophosmin/B23 is a negative regulator of estrogen receptor α expression via AP2γ in endometrial cancer cells.

Authors:  Chiao-Yun Lin; Angel Chao; Tzu-Hao Wang; Li-Yu Lee; Lan-Yan Yang; Chia-Lung Tsai; Hsin-Shih Wang; Chyong-Huey Lai
Journal:  Oncotarget       Date:  2016-09-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.